Ignite Creation Date:
2025-12-25 @ 12:22 AM
Ignite Modification Date:
2025-12-25 @ 10:27 PM
Study NCT ID:
NCT06340958
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-09-30
First Post:
2024-03-25
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
A Study of CLE-100 (Oral Esketamine) as an Adjunctive Treatment to Standard Antidepressants for Major Depressive Disorder
Sponsor:
Clexio Biosciences Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2024-03-18
Start Date Type:
ACTUAL
Primary Completion Date:
2025-06-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2026-01-10
Completion Date Type:
ESTIMATED
First Submit Date:
2024-03-25
First Submit QC Date:
None
Study First Post Date:
2024-04-02
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-09-25
Last Update Post Date:
2025-09-30
Last Update Post Date Type:
ESTIMATED